抗血小板聚集药在缺血性脑卒中的应用

[1] 抗血小板聚集药物防治缺血性卒中研究进展 [J]. 医药导报, 2009, 28 (02) : 140 - 145

[2] 缺血性卒中和短暂性脑缺血发作处理指南2008 [J]. 中华脑血管病杂志(电子版), 2008, (04) : 214 - 256

[3] 我国人群脑卒中发病率、死亡率的流行病学研究 [J]. 中华流行病学杂志, 2003, (03) : 71 - 74

[4] 血小板糖蛋白Ⅱb/Ⅲa受体拮抗剂在冠心病中的应用进展 [J]. 心血管病学进展, 2003, (01) : 52 - 55

[5] Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial[J] . Yukito Shinohara,Yasuo Katayama,Shinichiro Uchiyama,Takenori Yamaguchi,Shunnosuke Handa,Kempei Matsuoka,Yasuo Ohashi,Norio Tanahashi,Hiroko Yamamoto,Chokoh Genka,Yasuhisa Kitagawa,Hideo Kusuoka,Katsuya Nishimaru,Motoo Tsushima,Yukihiro Koretsune,Tohru Sawada,Chikuma Hamada.Lancet Neurology . 2010 (10)

[6] Guanxin II (冠心II号) for the management of coronary heart disease [J]. Chinese Journal of Integrative Medicine, 2009, 15 : 472 - 476

[7] Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study[J] . Lancet Neurology . 2008 (10)

[8] Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study[J] . Yining Huang,Yan Cheng,Jiang Wu,Yansheng Li,En Xu,Zhen Hong,Zhengyi Li,Weiwei Zhang,Meiping Ding,Xuguang Gao,Dongsheng Fan,Jinsheng Zeng,Kasing Wong,Chuanzhen Lu,Jiangxi Xiao,Chen Yao.Lancet Neurology . 2008 (6)

[9] Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack [J]. STROKE, 2008, 39 (05) : 1647 - 1652

[10] Cilostazol in secondary prevention of stroke: Impact of the Cilostazol Stroke Prevention Study[J] . Masayasu Matsumoto.Atherosclerosis (Supplements) (Component) . 2005 (4)

[1] 抗血小板聚集药物防治缺血性卒中研究进展 [J]. 医药导报, 2009, 28 (02) : 140 - 145

[2] 缺血性卒中和短暂性脑缺血发作处理指南2008 [J]. 中华脑血管病杂志(电子版), 2008, (04) : 214 - 256

[3] 我国人群脑卒中发病率、死亡率的流行病学研究 [J]. 中华流行病学杂志, 2003, (03) : 71 - 74

[4] 血小板糖蛋白Ⅱb/Ⅲa受体拮抗剂在冠心病中的应用进展 [J]. 心血管病学进展, 2003, (01) : 52 - 55

[5] Cilostazol for prevention of secondary stroke (CSPS 2): an aspirin-controlled, double-blind, randomised non-inferiority trial[J] . Yukito Shinohara,Yasuo Katayama,Shinichiro Uchiyama,Takenori Yamaguchi,Shunnosuke Handa,Kempei Matsuoka,Yasuo Ohashi,Norio Tanahashi,Hiroko Yamamoto,Chokoh Genka,Yasuhisa Kitagawa,Hideo Kusuoka,Katsuya Nishimaru,Motoo Tsushima,Yukihiro Koretsune,Tohru Sawada,Chikuma Hamada.Lancet Neurology . 2010 (10)

[6] Guanxin II (冠心II号) for the management of coronary heart disease [J]. Chinese Journal of Integrative Medicine, 2009, 15 : 472 - 476

[7] Effects of aspirin plus extended-release dipyridamole versus clopidogrel and telmisartan on disability and cognitive function after recurrent stroke in patients with ischaemic stroke in the Prevention Regimen for Effectively Avoiding Second Strokes (PRoFESS) trial: a double-blind, active and placebo-controlled study[J] . Lancet Neurology . 2008 (10)

[8] Cilostazol as an alternative to aspirin after ischaemic stroke: a randomised, double-blind, pilot study[J] . Yining Huang,Yan Cheng,Jiang Wu,Yansheng Li,En Xu,Zhen Hong,Zhengyi Li,Weiwei Zhang,Meiping Ding,Xuguang Gao,Dongsheng Fan,Jinsheng Zeng,Kasing Wong,Chuanzhen Lu,Jiangxi Xiao,Chen Yao.Lancet Neurology . 2008 (6)

[9] Update to the AHA/ASA recommendations for the prevention of stroke in patients with stroke and transient ischemic attack [J]. STROKE, 2008, 39 (05) : 1647 - 1652

[10] Cilostazol in secondary prevention of stroke: Impact of the Cilostazol Stroke Prevention Study[J] . Masayasu Matsumoto.Atherosclerosis (Supplements) (Component) . 2005 (4)